References: |
Ostarine (MK-2866) is an androgen receptor modulator (SARM) with an ED50 of 0.44 mg/day. Ostarine (MK-2866) has anabolic activity. Lack of PSA increases in men and hair growth in women further corroborated selective anabolic effects of Ostarine (MK-2866). Ostarine (MK-2866) also resulted in a dose-dependent decrease in LDL and HDL cholesterol levels, with the average LDL/HDL ratio for all doses remaining in the low cardiovascular risk catergory. For the detailed information of Ostarine(MK-2286), the solubility of Ostarine(MK-2286) in water, the solubility of Ostarine(MK-2286) in DMSO, the solubility of Ostarine(MK-2286) in PBS buffer, the animal experiment (test) of Ostarine(MK-2286), the cell expriment (test) of Ostarine(MK-2286), the in vivo, in vitro and clinical trial test of Ostarine(MK-2286), the EC50, IC50,and affinity,of Ostarine(MK-2286), For the detailed information of Ostarine(MK-2286), the solubility of Ostarine(MK-2286) in water, the solubility of Ostarine(MK-2286) in DMSO, the solubility of Ostarine(MK-2286) in PBS buffer, the animal experiment (test) of Ostarine(MK-2286), the cell expriment (test) of Ostarine(MK-2286), the in vivo, in vitro and clinical trial test of Ostarine(MK-2286), the EC50, IC50,and affinity,of Ostarine(MK-2286), Please contact DC Chemicals. |